News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
- UBS downgraded MTR to "Sell" citing high capex and weak land returns, despite short-term optimism over a HKD6B Tuen Mun project awarded to Sun Hung Kai. - The bank is liquidating O'Connor funds hit by First Brands' bankruptcy, expecting 70% recovery by year-end and 30% by 2025, highlighting systemic risks from the supplier's $10B liabilities. - UBS expands in India by leasing Mumbai office space at 460 rupees/sqft, reflecting cost-efficient post-merger integration and growth focus amid global economic un
- Centene's stock fell nearly 10% as Trump proposed redirecting ACA subsidies directly to individuals, bypassing insurers. - The GOP plan threatens insurers' business models, with Centene deriving 80% of revenue from government programs like Medicaid and ACA exchanges. - Market-wide declines in ACA-focused insurers and policy uncertainty over subsidy extensions amplified sector risks amid a 40-day government shutdown. - Centene's $5.29B loss and high debt-to-equity ratio highlight vulnerability to potentia
- 22:10The probability of a Fed rate cut in December is 64.1%, and the probability of a rate cut in January next year is 54.1%.ChainCatcher news, according to Golden Ten Data, CME "FedWatch" shows that the probability of the Federal Reserve cutting interest rates by 25 basis points in December is 64.1%, while the probability of keeping rates unchanged is 35.9%. By January next year, the probability of a cumulative 25 basis point rate cut is 54.1%, the probability of keeping rates unchanged is 23.2%, and the probability of a cumulative 50 basis point rate cut is 22.7%.
- 22:08Biotech company Propanc raises $100 million for crypto reserves and cancer therapy developmentJinse Finance reported that Australia-based Propanc Biopharma (NASDAQ: PPCB) announced on Monday that it has secured up to 100 million dollars in financing from Hexstone Capital. Hexstone Capital is a family office active in the fields of bitcoin, ethereum, solana, dogecoin, and other digital assets. This private placement deal, structured through convertible preferred shares, provides Propanc with an initial investment of 1 million dollars and up to an additional 99 million dollars in follow-up financing over the next year. The proceeds will be used to build Propanc's digital asset portfolio and accelerate the development of its leading tumor therapy, PRP, which is currently targeted for its first human trial in 2026. CEO James Nathanielsz described this move as a "transformational phase," though the company did not specify which digital assets it plans to acquire.
- 21:29The US Dollar Index fell by 0.02% on the 10th.Jinse Finance reported that the US Dollar Index fell by 0.02% on the 10th, closing at 99.589 in the late foreign exchange market.